ACX-01

N/A

Report date: 2025/11/24 11:13:08

Base Information

Drug NameACX-01
Drug Alias NameACX-01
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Fab fragment
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHead and Neck NeoplasmsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCentauri Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCentauri Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsHead and Neck NeoplasmsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A